Lombard Medical Technologies (NSDQ:EVAR) today said it won approval from the Japanese Ministry of Health for the AorFlex system used to implant its Aorfix stent graft, which is used to repair abdominal aortic aneurysms.
The Aorfix device won approval from the Japanese Ministry of Health last August, making it the 1st endovascular stent graft approved in Japan to treat aortic neck angulations up to 90°.
Lombard said it inked a deal to distribute the devices in Japan with Medico’s Hirata Inc.
"The Medico’s Hirata established sales force has made a great start since launching Aorfix in September 2014. Introducing the more advanced AorFlex delivery system with hydrophilic coating puts the Japanese Aorfix system in line with the other global regions and will create an even more compelling proposition and help continue the fantastic momentum we have already shown in Japan," Lombard Medical CEO Simon Hubbert said in prepared remarks.
Last month Lombard won a nod from the FDA for its larger Aorfix Plus device.
